⚕️ Compounded medications are not FDA-approved. Always consult a licensed provider. · Affiliate Disclosure
HomeBlog › What State Board of Pharmacy Inspections Actually Check
Regulation9 min read · July 2026

What State Board of Pharmacy Inspections Actually Check

Every compounding pharmacy in the United States is subject to inspection by the state board of pharmacy where it holds a license. These inspections are not optional — they are a condition of licensure. And what inspectors look for reveals a lot about what can go wrong when compounding quality slips.

If you're using a compounded GLP-1, your medication was prepared in a pharmacy that has been (or will be) inspected by state regulators. Understanding what those inspectors check helps you evaluate the pharmacy's compliance record — and ask smarter questions about the quality of what you're injecting.

Types of Inspections

Routine Inspections

Most state boards conduct routine inspections on a scheduled cycle — typically every one to three years, depending on the state and the pharmacy's risk profile. Sterile compounding pharmacies are generally inspected more frequently than standard dispensing pharmacies because the products they prepare carry higher patient safety risks.

For-Cause Inspections

These are triggered by complaints, adverse event reports, or referrals from other agencies (including the FDA). A for-cause inspection can happen at any time, without advance notice, and typically focuses on the specific concern that prompted it — though inspectors may expand scope if they identify additional problems.

Pre-Licensure Inspections

Before a pharmacy receives its initial compounding license or adds sterile compounding to its capabilities, most states require a pre-licensure inspection to verify that the facility, equipment, and personnel meet requirements before any compounding begins.

What Inspectors Look For

Facility and Equipment

Documentation and Records

Personnel Practices

Product Quality

What a Clean Inspection Record Means

A pharmacy with no deficiency citations over multiple inspection cycles is demonstrating consistent compliance — not just point-in-time readiness. This is a strong quality signal that's harder to fake than marketing claims.

Common Deficiency Findings

State board inspection reports are public records in most states. The most common deficiency findings in compounding pharmacy inspections include:

How to Check Your Pharmacy's Inspection Record

Most state boards of pharmacy maintain public databases where you can look up a pharmacy's license status, inspection history, and any disciplinary actions. The process varies by state:

Multi-State Licensing

Many compounding pharmacies that serve telehealth patients are licensed in multiple states — the state where the pharmacy is physically located, plus each state where they ship compounded prescriptions. This means they may be inspected by multiple state boards, each applying its own interpretation of USP standards. A pharmacy with clean inspection records across several states demonstrates consistent quality practices, not just compliance with one state's particular requirements.

Providers That Emphasize Pharmacy Compliance

Lead Pick

Embody

From $149/mo

Injectable semaglutide through established 503A pharmacy partnerships. Clinician-monitored dosing with direct pharmacy fulfillment.

Compounded medications are not FDA-approved.

Learn More Paid link
$100 Off Promo

Found Health

From $129/mo

Clinically-guided weight loss with GLP-1 options, behavior coaching, and metabolic tracking built in.

Compounded medications are not FDA-approved.

Learn More Paid link
Verified

Oak Health

From $175/mo

GLP-1 weight loss program with pharmacy-direct fulfillment and provider consultations included.

Compounded medications are not FDA-approved.

Learn More Paid link

Compare GLP-1 Providers Side by Side

See pricing, pharmacy credentials, and delivery formats for verified telehealth providers.

View Provider Comparison →

Sources

  1. NABP. "Guidelines for State Board of Pharmacy Compounding Inspections." 2024.
  2. USP. "General Chapter <797> Pharmaceutical Compounding — Sterile Preparations." Revised November 2023.
  3. FDA. "Inspections of Compounding Facilities." Compliance Program Guidance Manual, Chapter 29.
  4. Pharmacy Times. "State Boards of Pharmacy Intensify Compounding Oversight in Wake of Federal Regulatory Changes." 2025.

Affiliate Disclosure: Some links on this page are paid affiliate links. If you sign up through them, we may earn a commission at no extra cost to you. This does not influence our editorial content or provider evaluations.

Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

FDA Notice: Compounded medications referenced in this article are not FDA-approved. Only brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro) carry FDA approval for their indicated uses.